BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2834022)

  • 1. Effect of alpha 1-adrenoceptors blockade with prazosin in canine narcolepsy.
    Mignot E; Guilleminault C; Bowersox S; Rappaport A; Dement WC
    Brain Res; 1988 Mar; 444(1):184-8. PubMed ID: 2834022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of central alpha-1 adrenoceptors in canine narcolepsy.
    Mignot E; Guilleminault C; Bowersox S; Rappaport A; Dement WC
    J Clin Invest; 1988 Sep; 82(3):885-94. PubMed ID: 2843574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central alpha 1 adrenoceptor subtypes in narcolepsy-cataplexy: a disorder of REM sleep.
    Mignot E; Guilleminault C; Bowersox S; Frusthofer B; Nishino S; Maddaluno J; Ciaranello R; Dement WC
    Brain Res; 1989 Jun; 490(1):186-91. PubMed ID: 2569353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems.
    Mignot E; Nishino S; Sharp LH; Arrigoni J; Siegel JM; Reid MS; Edgar DM; Ciaranello RD; Dement WC
    J Neurosci; 1993 Mar; 13(3):1057-64. PubMed ID: 8095066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 levels in cerebrospinal fluid of normal and narcoleptic dogs.
    Nishino S; Mignot E; Kilduff TS; Sakai T; Hayaishi O; Dement WC
    Biol Psychiatry; 1990 Nov; 28(10):904-10. PubMed ID: 2268692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 and its methyl ester reduce cataplexy in canine narcolepsy.
    Nishino S; Mignot E; Fruhstorfer B; Dement WC; Hayaishi O
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2483-7. PubMed ID: 2928344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep.
    Nishino S; Haak L; Shepherd H; Guilleminault C; Sakai T; Dement WC; Mignot E
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1145-52. PubMed ID: 1972749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs.
    Wagner JL; Storb R; Storer B; Mignot E
    Tissue Antigens; 2000 Sep; 56(3):223-31. PubMed ID: 11034558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation.
    Reid MS; Tafti M; Geary JN; Nishino S; Siegel JM; Dement WC; Mignot E
    Neuroscience; 1994 Apr; 59(3):511-22. PubMed ID: 8008205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of cataplexy in genetically narcoleptic Dobermans.
    Riehl J; Nishino S; Cederberg R; Dement WC; Mignot E
    Exp Neurol; 1998 Aug; 152(2):292-302. PubMed ID: 9710528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.
    Lin L; Faraco J; Li R; Kadotani H; Rogers W; Lin X; Qiu X; de Jong PJ; Nishino S; Mignot E
    Cell; 1999 Aug; 98(3):365-76. PubMed ID: 10458611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep studies on canine narcolepsy: pattern and cycle comparisons between affected and normal dogs.
    Mitler MM; Dement WC
    Electroencephalogr Clin Neurophysiol; 1977 Nov; 43(5):691-9. PubMed ID: 72649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic mechanisms in canine narcolepsy--II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexy.
    Reid MS; Siegel JM; Dement WC; Mignot E
    Neuroscience; 1994 Apr; 59(3):523-30. PubMed ID: 8008206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep fragmentation in canine narcolepsy.
    Kaitin KI; Kilduff TS; Dement WC
    Sleep; 1986; 9(1 Pt 2):116-9. PubMed ID: 3704433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cataplexy-related neurons in the amygdala of the narcoleptic dog.
    Gulyani S; Wu MF; Nienhuis R; John J; Siegel JM
    Neuroscience; 2002; 112(2):355-65. PubMed ID: 12044453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy.
    Nishino S; Fruhstorfer B; Arrigoni J; Guilleminault C; Dement WC; Mignot E
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1079-84. PubMed ID: 8095546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical studies of human narcolepsy: alpha-adrenergic receptor autoradiography of human narcoleptic brain and brainstem.
    Aldrich MS; Prokopowicz G; Ockert K; Hollingsworth Z; Penney JB; Albin RL
    Sleep; 1994 Oct; 17(7):598-608. PubMed ID: 7846457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine narcolepsy is associated with an elevated number of alpha 2-receptors in the locus coeruleus.
    Fruhstorfer B; Mignot E; Bowersox S; Nishino S; Dement WC; Guilleminault C
    Brain Res; 1989 Oct; 500(1-2):209-14. PubMed ID: 2557958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic studies in narcolepsy, a disorder affecting REM sleep.
    Faraco J; Lin X; Li R; Hinton L; Lin L; Mignot E
    J Hered; 1999; 90(1):129-32. PubMed ID: 9987919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet alpha 2 adrenoceptors in human and canine narcolepsy.
    Valtier D; Nishino S; Guilleminault C; Dement WC; Mignot E
    Biol Psychiatry; 1991 Feb; 29(4):376-82. PubMed ID: 1645207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.